BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:40:00 PM | Browse: 1416 | Download: 1563
 |
Received |
|
2013-05-19 10:38 |
 |
Peer-Review Started |
|
2013-05-20 12:13 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-07-20 20:14 |
 |
Revised |
|
2013-08-04 20:01 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-09-05 11:20 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-09-05 12:51 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-09-26 19:58 |
 |
Publish the Manuscript Online |
|
2013-10-15 17:26 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Epidermal growth factor receptor and metastatic colorectal cancer: Insights into target therapies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ramon Andrade de Mello, Andrea Marin Marques and António Araújo |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ramon Andrade de Mello, MD, PhD, Department of Medical Oncology, Portuguese Oncology Institute, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. ramondemello@gmail.com |
| Key Words |
Colorectal cancer; Epidermal growth factor receptor; KRAS mutation; Chemotherapy; Cetuximab; Panitumumab |
| Core Tip |
Metastatic colorectal cancer (mCRC) remains a challenge for oncologists worldwide. Despite a very aggressive disease profile, mCRC’s outcomes are improving toward last decades. Target drugs, such as cetuximab and panitumumab, acquired a main role in this scenario whether phase Ⅲ trials showed interesting results in overall survival and disease control. Thus, we will briefly in this paper discuss some issues and pitfalls concerning this framework. |
| Publish Date |
2013-10-15 17:26 |
| Citation |
de Mello RA, Marques AM, Araújo A. Epidermal growth factor receptor and metastatic colorectal cancer: Insights into target therapies. World J Gastroenterol 2013; 19(38): 6315-6318 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i38/6315.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i38.6315 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.